MediciNova, Inc. (MNOV)
1.78
+0.15
(+9.20%)
USD |
NASDAQ |
Oct 02, 16:00
1.80
+0.02
(+1.12%)
After-Hours: 20:00
MediciNova EPS Diluted (Quarterly) : -0.047 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.047 |
| March 31, 2026 | -0.0525 |
| December 31, 2025 | -0.057 |
| September 30, 2025 | -0.0622 |
| June 30, 2025 | -0.0669 |
| March 31, 2025 | -0.0584 |
| December 31, 2024 | -0.0574 |
| September 30, 2024 | -0.0582 |
| June 30, 2024 | -0.0536 |
| March 31, 2024 | -0.0562 |
| December 31, 2023 | -0.042 |
| September 30, 2023 | -0.0147 |
| June 30, 2023 | -0.0586 |
| March 31, 2023 | -0.0595 |
| December 31, 2022 | -0.0612 |
| September 30, 2022 | -0.0745 |
| June 30, 2022 | -0.0822 |
| March 31, 2022 | -0.069 |
| December 31, 2021 | -0.0425 |
| September 30, 2021 | -0.0731 |
| June 30, 2021 | -0.0878 |
| March 31, 2021 | -0.004 |
| December 31, 2020 | -0.0663 |
| September 30, 2020 | -0.083 |
| June 30, 2020 | -0.101 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.0617 |
| December 31, 2019 | -0.0452 |
| September 30, 2019 | -0.0549 |
| June 30, 2019 | -0.0901 |
| March 31, 2019 | -0.1106 |
| December 31, 2018 | -0.0049 |
| September 30, 2018 | -0.16 |
| June 30, 2018 | -0.08 |
| March 31, 2018 | -0.12 |
| December 31, 2017 | -0.044 |
| September 30, 2017 | -0.11 |
| June 30, 2017 | -0.08 |
| March 31, 2017 | -0.09 |
| December 31, 2016 | -0.04 |
| September 30, 2016 | -0.08 |
| June 30, 2016 | -0.10 |
| March 31, 2016 | -0.11 |
| December 31, 2015 | -0.09 |
| September 30, 2015 | -0.06 |
| June 30, 2015 | -0.09 |
| March 31, 2015 | -0.09 |
| December 31, 2014 | -0.10 |
| September 30, 2014 | -0.10 |
| June 30, 2014 | -0.09 |
| March 31, 2014 | -0.10 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 0.3068 |
| Viking Therapeutics, Inc. | -1.101 |
| IDEAYA Biosciences, Inc. | -1.222 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.314M |
| Revenue (Quarterly) | 0.4584M |
| Total Expenses (Quarterly) | 2.773M |
| Enterprise Value | 62.31M |
| Gross Profit Margin (Quarterly) | 68.22% |
| Profit Margin (Quarterly) | -504.8% |
| Earnings Yield | -12.29% |
| Normalized Earnings Yield | -12.29 |